← Eichor
Study identifier: NCT06107686 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Study of YL202 in Selected Patients With Advanced Solid Tumors

Condition: NSCLC · Breast Cancer · HNSCC  ·  Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.

PhasePhase 2
Planned participants200
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This study is a multicenter, open-label, phase II study of YL202 in China to evaluate the efficacy, safety, and PK characteristics of YL202 in the following selected patients with advanced solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (82)

Anhui Tumour HospitalHefei, Anhui, ChinaRecruiting
The first affiliated hospital of Anhui Medical UniversityHefei, Anhui, ChinaRecruiting
The Second Hospital of Anhui Medical UniversityHefei, Anhui, ChinaNot Yet Recruiting
Beijing Cancer hospitalBeijing, Beijing Municipality, ChinaRecruiting
Beijing Tsinghua Chang Gung HospitalBeijing, Beijing Municipality, ChinaNot Yet Recruiting
Peking University Third HospitalBeijing, Beijing Municipality, ChinaRecruiting
Chinese First Affiliated Hospital of Army Medical University of the People's Liberation ArmyChongqing, Chongqing Municipality, ChinaNot Yet Recruiting
Chongqing University Affiliated Tumor HospitalChongqing, Chongqing Municipality, ChinaRecruiting
The first affiliated hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaNot Yet Recruiting
Xinqiao Hospital of AMUChongqing, Chongqing Municipality, ChinaRecruiting
Xinqiao HospitalChongqing, Chongqing Municipality, ChinaRecruiting

+ 70 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06107686